Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.
Feb 28, 2024
0
32
A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has demonstrated for the first time that the diagnosis of multiple sclerosis (MS) can be significantly improved ...
Jul 6, 2023
0
50
Injuries to the nerves can blind or paralyze because adult nerve cells don't regenerate their connections. Now, a team of UConn School of Medicine researchers report in Development that in everyone there exists at least a ...
May 31, 2023
0
62
A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School ...
Feb 9, 2017
0
47
An epilepsy drug could lead to a new treatment that protects nerve damage in MS patients, according to research published in the Lancet Neurology.
Jan 25, 2016
0
196
(Medical Xpress)—Biogen Idec Inc has released preliminary results of a phase II clinical trial (called RENEW) meant to test the effectiveness of using an anti-LINGO-1 drug called BIIB033, to treat eye damage that occurs ...
A universal criteria for diagnosing the blinding eye condition optic neuritis has been developed by a UCL-led team of researchers.
Jan 12, 2023
0
4
It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first ...
Aug 10, 2022
0
49
In a clinical trial of 113 patients led by researchers at Imperial College London and UCL, retinal imaging technology called Detection of Apoptosis in Retinal Cells (DARC) was able to identify areas of the eye that were showing ...
Aug 13, 2021
0
7
Multiple sclerosis is the ultimate chameleon.
Mar 3, 2021
0
5
